US Map / Louisiana
State LA

Clinical Trials in Louisiana

Louisiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Louisiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 132 actively recruiting studies with Louisiana sites out of 132 registered in total. The busiest research areas in Louisiana are Obesity, Overweight, Hypertension. Leading sponsors running trials in the state include Pennington Biomedical Research Center, AstraZeneca, Tulane University. By stage, Louisiana trials break down as Phase 1 (10), Phase 2 (27), Phase 3 (57), Phase 4 (4).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
132
Recruiting Now
132
← Back to US Map
Top Conditions in Louisiana
Obesity (7)Overweight (4)Hypertension (3)Systemic Sclerosis (3)Healthy (2)Ulcerative Colitis (2)Multiple Myeloma (2)Non-small Cell Lung Cancer (2)Colorectal Cancer (CRC) (2)Crohn's Disease (2)Pancreatic Adenocarcinoma (2)Asthma (2)

Frequently Asked Questions — Clinical Trials in Louisiana

How many clinical trials are currently recruiting in Louisiana?
ClinicalMetric currently tracks 132 actively recruiting clinical trials with at least one location in Louisiana. The total number of registered studies—including active but not currently enrolling trials—is 132. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Louisiana?
Louisiana hosts clinical trials across a broad range of medical conditions, including Obesity, Overweight, Hypertension, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Louisiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Louisiana?
To join a clinical trial in Louisiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Louisiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Louisiana

NCT06428643 N/A
Recruiting
A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities
Condition
Chlamydia
Enrollment
2,322 pts
Location
United States
Sponsor
Tulane University
View Trial →
NCT06617325 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Part...
Condition
Systemic Lupus Erythematosus
Enrollment
450 pts
Location
United States, Argentina, Belgium
Sponsor
UCB Biopharma SRL
View Trial →
NCT06875973 Phase 3
Recruiting
Pelacarsen Roll-over Extension Program
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
599 pts
Location
United States, Puerto Rico
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06072781 Phase 3
Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade ...
Condition
Low Grade Serous Ovarian Cancer
Enrollment
270 pts
Location
United States, Australia, Belgium
Sponsor
Verastem, Inc.
View Trial →
NCT06252922 N/A
Recruiting
Diet-Induced Changes in GEnetic Material
Condition
Diet, Healthy
Enrollment
10 pts
Location
United States
Sponsor
Pennington Biomedical Research
View Trial →
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT07160244 Phase 3
Recruiting
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregn...
Condition
Healthy
Enrollment
6,000 pts
Location
United States, Argentina, Brazil
Sponsor
Pfizer
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07165028 Phase 3
Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease
Enrollment
4,500 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
View Trial →
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
View Trial →
NCT07288398 Phase 3
Recruiting
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Condition
Pulmonary Hypertension Associated With HFpEF
Enrollment
540 pts
Location
United States, Argentina, Austria
Sponsor
Tenax Therapeutics, Inc.
View Trial →
NCT06059638 N/A
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Condition
Hypertension
Enrollment
316 pts
Location
United States, Australia, Belgium
Sponsor
Orchestra BioMed, Inc
View Trial →
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT04228978 N/A
Recruiting
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent...
Condition
Peripheral Artery Disease
Enrollment
212 pts
Location
United States
Sponsor
Northwestern University
View Trial →
NCT01524276 N/A
Recruiting
Product Surveillance Registry
Condition
Cardiac Rhythm Disorders
Enrollment
100,000 pts
Location
United States, Argentina, Australia
Sponsor
Medtronic
View Trial →
NCT07218926 Phase 3
Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastr...
Condition
Gastrointestinal Neoplasms
Enrollment
450 pts
Location
United States, Australia, Belgium
Sponsor
GlaxoSmithKline
View Trial →
NCT07226973 N/A
Recruiting
Gait After THA: Direct Anterior vs Manual Posterior vs Robotic Posterior
Condition
Osteoarthritis (OA) of the Hip
Enrollment
48 pts
Location
United States
Sponsor
Ochsner Health System
View Trial →
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
LEO Pharma
View Trial →
NCT04956445 N/A
Recruiting
Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasur...
Condition
Covid19
Enrollment
2,000 pts
Location
United States
Sponsor
Tulane University
View Trial →
NCT05519475 Phase 2
Recruiting
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Dise...
Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Enrollment
120 pts
Location
United States, Japan, Puerto Rico
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06095128 Phase 4
Recruiting
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Condition
Ulcerative Colitis
Enrollment
65 pts
Location
United States, Canada
Sponsor
Takeda
View Trial →
NCT07227311 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combinati...
Condition
Multiple Myeloma
Enrollment
200 pts
Location
United States, France, Germany
Sponsor
GlaxoSmithKline
View Trial →
NCT06218875 N/A
Recruiting
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endopros...
Condition
AAA - Abdominal Aortic Aneurysm
Enrollment
2,000 pts
Location
United States, Australia, Austria
Sponsor
W.L.Gore & Associates
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT06692738 Phase 3
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for...
Condition
Non-small Cell Lung Cancer
Enrollment
1,160 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
Page 1 of 6 — 132 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology